PROSIT Retinopathy Diabetes Models

Jenissei B Model

Latest Release: 15. October 2018

Latest Version: PROSIT Retinopathy Type 2 Diabetes Disease Model 2018B Germany

Summary: Jenissei B: Adapted transition probabilities from Jenissei A. The model is open for discussion: use the discussion link at the top of this page.

Methodology: Markov model (Markov process)

Health Economic Perspective: flexible, dependent on user specification

Time Horizon: 80 cycles; currently defined as annual time steps

Patient Cohort: realistic diabetes cohort for Germany and type 2 diabetes mellitus based on the ProValue study. Divided into up to 16 sub-cohorts. Cohort specifications can be edited freely.

Costs: summary costs for Germany are included based on the KODIM Cost study and results being inflationed to the year 2015. Costs can be edited freely.

Other specifications: the model supports QALYS, and discounting of both costs and effects. The half-cycle correction is implemented as within-cycle correction.

Team Members: Fabian Sailer, Monika Pobiruchin, Wendelin Schramm

Previous Versions: PROSIT Retinopathy Type 2 Diabetes Disease Model 2016B Germany (from 25. July 2017)

JenisseiA Model

Structure of the PROSIT Retinopathy Diabetes Disease Model Jenissei A

RhenusA Model

This model version has been replaced by the Jenissei model and is not supported any more since 2013.

Discontinued Versions of Rhenus A: The versions below are based on the pre 2012 modelling procedures and have been abandoned. The structure was used for later models.

Summary: n.a.

Team Members: Tilman Stripf, Yasaman Alimohammadi, Wendelin Schramm